Baeuerle Patrick Insider Trades

Insider Trading History

Track insider trading activity for Baeuerle Patrick. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Chief Scientific Officer
Holding Value $1.17M 77,000 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$873k 77,000 shares
$11.34
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $1.14M 75,000 shares
Last Trade
Feb 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 75,000 shares
$13.60
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $3.65M 240,114 shares
Last Trade
Sep 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 11,000 shares
$28.91
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $0 0 shares
Last Trade
Sep 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$313k 11,000 shares
$28.45
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $167k 11,000 shares
Last Trade
Sep 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 11,000 shares
$28.91
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $0 0 shares
Last Trade
Aug 10, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$297k 11,000 shares
$27.00
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $3.82M 251,114 shares
Last Trade
Aug 10, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$313k 11,000 shares
$28.49
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $167k 11,000 shares
Last Trade
Aug 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$313k 11,000 shares
$28.49
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $4.36M 286,665 shares
Last Trade
Jan 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.73k 286,665 shares
$0.02
$15.21
Cullinan Therapeutics
Cullinan Therapeutics CGEM
See Remarks
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale
$8.16k 407,993 shares
$0.02
$15.21
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Director
Holding Value $17.9k 12,100 shares
Last Trade
Dec 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$385k 12,100 shares
$31.83
$1.48
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $234k 10,167 shares
Last Trade
May 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.63M 12,751 shares
$205.90
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $6.3M 273,953 shares
Last Trade
Dec 27, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.8M 87,379 shares
$169.50
$23.01
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Director
Holding Value $519k 350,786 shares
Last Trade
Dec 23, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.31M 84,907 shares
$15.44
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Director
Holding Value $645k 435,693 shares
Last Trade
Dec 20, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$485k 32,022 shares
$15.16
$1.48
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $234k 10,167 shares
Last Trade
Jun 03, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 10,167 shares
$118.40
$23.01
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Director
Holding Value $88.6k 59,850 shares
Last Trade
Apr 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$964k 59,850 shares
$16.11
$1.48
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $0 0 shares
Last Trade
Feb 07, 2019 Sale
No data
No data
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
Director
Holding Value $88.1k 3,829 shares
Last Trade
Feb 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$23.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up